Patents by Inventor Eric T. Fung

Eric T. Fung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR OVARIAN CANCER CTAP3-RELATED PROTEINS
    Publication number: 20220317126
    Abstract: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 17, 2021
    Publication date: October 6, 2022
    Applicants: Aspira Women's Health Inc., The Johns Hopkins University
    Inventors: Zhen ZHANG, Daniel W. CHAN, Eric T. FUNG, Zheng WANG, Fujun ZHANG
  • Biomarkers for ovarian cancer CTAP3-related proteins
    Patent number: 11255857
    Abstract: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: February 22, 2022
    Assignees: Aspira Women's Health Inc., The Johns Hopkins University
    Inventors: Zhen Zhang, Daniel W. Chan, Eric T. Fung, Zheng Wang, Fujun Zhang
  • BIOMARKERS FOR OVARIAN CANCER CTAP3-RELATED PROTEINS
    Publication number: 20180196054
    Abstract: The present invention provides a protein-based biomarker that is useful qualifying ovarian cancer status to a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: November 10, 2017
    Publication date: July 12, 2018
    Applicants: VERMILLION, INC., THE JOHNS HOPKINS UNIVERSITY
    Inventors: ZHEN ZHANG, DANIEL W. CHAN, ERIC T. FUNG, ZHENG WANG, FUJUN ZHANG
  • Biomarker for ovarian cancer CTAP3-related proteins
    Patent number: 9816995
    Abstract: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: November 14, 2017
    Assignees: Vermillion, Inc., The Johns Hopkins University
    Inventors: Zhen Zhang, Daniel W. Chan, Eric T. Fung, Zheng Wang, Fujun Zhang
  • BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN
    Publication number: 20150153348
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 4, 2013
    Publication date: June 4, 2015
    Applicant: Vermillion, Inc.
    Inventors: Eric T. Fung, Enrique Dalmasso, Valdimir Podust, Zheng Wang
  • Prognostic Biomarkers in Patients with Ovarian Cancer
    Publication number: 20150126384
    Abstract: The present invention provides methods for assessing an ovarian cancer patient's survival status. Also, methods for evaluating the ovarian cancer state of a patient are described herein. These methods involve the detection, analysis, and classification of biological patterns in biological samples. The biological patterns are obtained using, for example, mass spectrometry systems and other techniques.
    Type: Application
    Filed: November 6, 2013
    Publication date: May 7, 2015
    Applicant: VERMILLION, INC.
    Inventors: Estrid Hogdall, Eric T. Fung, Jarle IB Christensen, Claus Hogdall
  • BIOMARKER FOR OVARIAN CANCER CTAP3-RELATED PROTEINS
    Publication number: 20140274787
    Abstract: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicants: Vermillion, Inc., The Johns Hopkins University
    Inventors: ZHEN ZHANG, DANIEL W. CHAN, ERIC T. FUNG, ZHENG WANG, FUJUN ZHANG
  • ?-2 microglobulin as a biomarker for peripheral artery disease
    Patent number: 8709735
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: April 29, 2014
    Assignees: Vermillion, Inc., Board of Trustees of of the Leland Stanford Junior University
    Inventors: John P. Cooke, Eric T. Fung, Elichiro Kimura
  • BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE
    Publication number: 20130260389
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Application
    Filed: January 16, 2013
    Publication date: October 3, 2013
    Applicants: Board of Trustees of the Leland Stanford Junior Un University, Vermillion, Inc.
    Inventors: John P. Cooke, Eric T. Fung, Eiichiro Kimura
  • Biomarkers for ovarian cancer
    Patent number: 8465929
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: June 18, 2013
    Assignees: Vermillion, Inc., The University of Kentucky Research Foundation
    Inventors: Eric T. Fung, Frederick R. Ueland, J. R. van Nagell, Paul D. Depriest, Andre T. Baron
  • Beta-2 microglobulin as a biomarker for peripheral artery disease
    Patent number: 8377646
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: February 19, 2013
    Assignees: Vermillion, Inc., Board of Trustees of the Leland Standford Junior University
    Inventors: John P. Cooke, Eric T. Fung, Eiichiro Kimura
  • Biomarkers for ovarian cancer
    Patent number: 8221984
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, it has been found that the biomarkers set forth in Table 1 are biomarkers for ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: July 17, 2012
    Assignees: Vermillion, Inc., Board of Regents, The University of Texas System
    Inventors: Eric T. Fung, Robert Bast, Vladimir Podust, Charlotte Clarke
  • BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE
    Publication number: 20120077708
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 29, 2012
    Applicants: Board of Trustees of the Leland Stanford Junior University, VERMILLION, INC.
    Inventors: John Cooke, Eric T. Fung, Eiichiro Kimura
  • BIOMARKERS FOR PERIPHERAL ARTERY DISEASE
    Publication number: 20110313681
    Abstract: This invention provides biomarkers whose concentrations in blood plasma are associated with the presence or absence of PAD in the patient from whom the plasma sample is taken. The invention also provides biomarkers for distinguishing between PAD patients who are long claudicators and PAD patients who are not. In addition, the invention provides methods for identifying additional biomarkers, methods for detecting the biomarkers in patients, and methods for identifying agents, including pharmaceutical agents, which interact with the biomarkers and are useful for preventing or treating PAD in patients.
    Type: Application
    Filed: August 25, 2011
    Publication date: December 22, 2011
    Applicants: Vermillion, Inc., Board of Trustees of the Leland Stanford Junior University
    Inventors: Eric T. Fung, John P. Cooke, Xiao-Ying Meng, Tai-Tung Yip, Fujan Zhang
  • Beta-2 microglobulin as a biomarker for peripheral artery disease
    Patent number: 8053204
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: November 8, 2011
    Assignees: Vermillion, Inc., Board of Trustees of the Leland Stanford Junior University
    Inventors: John Cooke, Eric T. Fung, Eiichiro Kimura
  • Biomarkers for peripheral artery disease
    Patent number: 8008020
    Abstract: This invention provides biomarkers whose concentrations in blood plasma are associated with the presence or absence of PAD in the patient from whom the plasma sample is taken. The invention also provides biomarkers for distinguishing between PAD patients who are long claudicators and PAD patients who are not. In addition, the invention provides methods for identifying additional biomarkers, methods for detecting the biomarkers in patients, and methods for identifying agents, including pharmaceutical agents, which interact with the biomarkers and are useful for preventing or treating PAD in patients.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: August 30, 2011
    Assignees: Vermillion, Inc., Board of Trustees of the Leland Stanford Junior University
    Inventors: Eric T. Fung, John P. Cooke, Xiao-Ying Meng, Tai-Tung Yip, Fujun Zhang
  • Panel of biomarkers for peripheral arterial disease
    Patent number: 7998743
    Abstract: The invention provides biomarkers including ?-2-microglobulin, Cystatin C, hsCRP and glucose as well as methods for using the biomarkers for diagnosing and/or assessing the risk of peripheral artery disease in a subject. In some embodiments, the subject being tested may be suffering from or at risk of other circulatory diseases, including coronary artery disease. Hemoglobin A1c or other proxies for measuring glucose levels may be substituted for or measured in addition to glucose in the context of the present invention.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: August 16, 2011
    Assignees: Vermillion, Inc., Board of Trustees of the Leland Stanford Junior University
    Inventors: Eric T. Fung, John Cooke, Fujun Zhang, Andrew Wilson
  • BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE
    Publication number: 20110151481
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Application
    Filed: December 20, 2010
    Publication date: June 23, 2011
    Applicant: VERMILLLION, INC.
    Inventors: John Cooke, Eric T. Fung, Eiichiro Kimura
  • Biomarkers for breast cancer
    Patent number: 7951529
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as breast cancer or non-breast cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: September 16, 2005
    Date of Patent: May 31, 2011
    Assignees: The Johns Hopkins University, Vermillion, Inc.
    Inventors: Jinong Li, Carolyn N. White, Zhen Zhang, Daniel W. Chan, Eric T. Fung, Xiao-Ying Meng
  • Beta-2 microglobulin as a biomarker for peripheral artery disease
    Patent number: 7867719
    Abstract: The present invention provides ?2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: January 11, 2011
    Assignees: Vermillion, Inc., The Board of Trustees of the Leland Stanford Junior University, Ajinomoto Co., Inc.
    Inventors: John Cooke, Eric T. Fung, Eiichiro Kimura